Patents by Inventor Ernst John Schaefer

Ernst John Schaefer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CLINICAL BENEFITS OF EICOSAPENTAENOIC ACID IN HUMANS
    Publication number: 20130261180
    Abstract: Methods are provided for maintaining or lowering lipoprotein-associated phospholipase A2 [“Lp-PLA2”] levels, stabilizing rupture prone-atherosclerotic lesions, decreasing the Inflammatory Index and increasing Total Omega-3 Score™ in humans, by administering an effective amount of eicosapentaenoic acid [“EPA”], an omega-3 polyunsaturated fatty acid [“PUFA”].
    Type: Application
    Filed: May 24, 2013
    Publication date: October 3, 2013
    Applicant: E I DU PONT DE NEMOURS AND COMPANY
    Inventors: Peter John Gillies, Ernst John Schaefer
  • CLINICAL BENEFITS OF EICOSAPENTAENOIC ACID IN HUMANS
    Publication number: 20110178105
    Abstract: Methods are provided for maintaining or lowering lipoprotein-associated phospholipase A2 [“Lp-PLA2”] levels, stabilizing rupture prone-atherosclerotic lesions, decreasing the Inflammatory Index and increasing Total Omega-3 Score™ in humans, by administering an effective amount of eicosapentaecnoic acid [“EPA”], an omega-3 polyunsaturated fatty acid [“PUFA”].
    Type: Application
    Filed: January 10, 2011
    Publication date: July 21, 2011
    Applicant: E.I. DU PONT DE NEMOURS AND COMPANY
    Inventors: PETER JOHN GILLIES, Ernst John Schaefer